Newsroom

LONDON--(BUSINESS WIRE)--The London and Hong Kong-based interior design and architecture studio Conran and Partners has joined the global integrated design firm DLR Group....

香港--(BUSINESS WIRE)--(美國商業資訊)-- 全球性綜合設計公司DLR Group今天宣布，總部位於倫敦和香港的室內設計與建築事務所Conran and Partners已正式加入該集團。Conran and Partners成為DLR Group在歐洲的首間事務所，並將以「Conran and Partners, a DLR Group studio」的名義經營，其香港事務所也將沿用此名稱。 Conran and Partners在國際上享有盛譽，以其在豪華飯店與度假村、品牌住宅與高端住宅開發，以及為國際知名客戶打造的客製化辦公與零售空間設計而聞名。該事務所傳承了Terence Conran爵士的設計理念，始終堅信優秀的設計能夠提升人們的生活品質。 「Conran and Partners是歐洲乃至全球豪華設計的代名詞。」DLR Group執行長Steven McKay（AIA及RIBA會員）表示，「我們雙方都堅信，設計具有提升人類體驗的力量。Conran and Partners的加入不僅帶來了一家頂級設計工作室，更提升了工藝水準，立即讓我們為歐洲、中東、亞洲及美...

SINGAPORE--(BUSINESS WIRE)--NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, SOUTH AFRICA OR JAPAN, EXCEPT AS PERMITTED BY APPLICABLE LAW, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION IS UNLAWFUL OR REQUIRES REGISTRATION OR ANY OTHER MEASURES. THIS ANNOUNCEMENT IS NOT AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN FOR SALE IN THE UNITED STATES. THE SECURITIES...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Alerian Disruptive Technology Real Estate UCITS ETF 23.09.2026 LANDXEN.LN IE000C75IMX8 15,878.00 USD 307,437.36 19.362  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Alerian Disruptive Technology Real Estate UCITS ETF 23.09.2026 LANDXN.LN IE000RN036E0 34,035.00 USD 728,055.43 21.391  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Global Equity Income UCITS ETF 23.09.2026 FGBL.LN IE00BYTH6121  781,089.00 USD  79,329,302.15  101.562  ...

SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced Phase 3 enabling topline results from the Phase 2 portion of the ongoing RADIANT clinical trial program evaluating remlifanserin for the treatment of hallucinations and delusions associated with Alzheimer’s disease psychosis (ADP). For the primary endpoint of change from baseline in the Scale for the Assessment of Positive Symptoms-Hallucinations and Delusions subscales (SAPS-H+D), once daily 60 mg remlifanse...

CLEARWATER, Fla. & FREMONT, Calif.--(BUSINESS WIRE)--TD SYNNEX (NYSE: SNX) today announced financial results for the fiscal third quarter ended August 31, 2026. Consolidated Financial Highlights for the Fiscal 2026 Third Quarter GAAP ($ in millions, except earnings per share)                 Q3 FY26   Q3 FY25   Net Change from Q3 FY25 Revenue   $ 21,558     $ 15,651     37.7 % Gross profit   $ 1,425     $ 1,130     26.2 % Gross margin     6.61 %     7.22 %   (61) bps Operating income   $ 643  ...

NEW YORK--(BUSINESS WIRE)--Starboard Value LP (together with its affiliates, “Starboard”), a stockholder of Knife River Corporation (“Knife River” or the “Company”) (NYSE: KNF), today announced that it has delivered a letter to Brian Gray, the Company’s President and Chief Executive Officer, with a copy to the Company’s Board of Directors. The full text of Starboard's letter to the Company can be viewed here. About Starboard Value LP Starboard Value LP is an investment adviser with a focused an...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Indxx Innovative Transaction & Process UCITS ETF 23.09.2026 LEGR LN IE00BF5DXP42 925,002.00 USD 51,026,859.71 55.164  ...